These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31865815)

  • 21. Are There Differences Between Intradermal and Intramuscular Injections of Botulinum Toxin on the Forehead?
    Kim YJ; Lim OK; Choi WJ
    Dermatol Surg; 2020 Dec; 46(12):e126-e131. PubMed ID: 32205751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin for masseter hypertrophy.
    Fedorowicz Z; van Zuuren EJ; Schoones J
    Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD007510. PubMed ID: 24018587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin for masseter hypertrophy.
    Al-Muharraqi MA; Fedorowicz Z; Al Bareeq J; Al Bareeq R; Nasser M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD007510. PubMed ID: 19160335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of forehead/glabellar rhytide complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin A injection alone: a split-face, rater-blinded, randomized control trial.
    Dubina M; Tung R; Bolotin D; Mahoney AM; Tayebi B; Sato M; Mulinari-Brenner F; Jones T; West DP; Poon E; Nodzenski M; Alam M
    J Cosmet Dermatol; 2013 Dec; 12(4):261-6. PubMed ID: 24305424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin type A: history and current cosmetic use in the upper face.
    Carruthers A
    Dis Mon; 2002 May; 48(5):299-322. PubMed ID: 12195262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Split face comparison between common concentration vs double dilution of intradermal abobotulinum toxin type A (Dysport) injection for facial lifting in Asians.
    Sirithanabadeekul P; Lapsomboonsiri S; Rungjang A; Thanasarnaksorn W
    J Cosmet Dermatol; 2018 Jun; 17(3):355-360. PubMed ID: 29878718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiologic change and facial contour following botulinum toxin A injection in square faces.
    Lee CJ; Kim SG; Kim YJ; Han JY; Choi SH; Lee SI
    Plast Reconstr Surg; 2007 Sep; 120(3):769-778. PubMed ID: 17700130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect analysis of intradermal hyaluronic acid injection to treat enlarged facial pores.
    Qian W; Zhang YK; Hou Y; Lyu W; Cao Q; Li YQ; Fan JF
    J Cosmet Dermatol; 2018 Aug; 17(4):596-599. PubMed ID: 28786543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ophthalmic adverse events following facial injections of botulinum toxin A: A systemic literature review.
    Skorochod R; Nesher R; Nesher G; Gronovich Y
    J Cosmet Dermatol; 2021 Aug; 20(8):2409-2413. PubMed ID: 34097809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial.
    Zimbler MS; Holds JB; Kokoska MS; Glaser DA; Prendiville S; Hollenbeak CS; Thomas JR
    Arch Facial Plast Surg; 2001; 3(3):165-9. PubMed ID: 11497500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin type a injection for lateral canthal rhytids : effect on tear film stability and tear production.
    Ho MC; Hsu WC; Hsieh YT
    JAMA Ophthalmol; 2014 Mar; 132(3):332-7. PubMed ID: 24385079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Midface lifting with botulinum toxin: intradermal technique.
    Petchngaovilai C
    J Cosmet Dermatol; 2009 Dec; 8(4):312-6. PubMed ID: 19958437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment.
    Xie Y; Zhou J; Li H; Cheng C; Herrler T; Li Q
    Plast Reconstr Surg; 2014 Aug; 134(2):209e-218e. PubMed ID: 25068343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Intradermal Injection of Botulinum Toxin A for Facial Lifting.
    Atwa EM; Nasr MM; Ebrahim HM
    J Clin Aesthet Dermatol; 2020 Dec; 13(12):22-26. PubMed ID: 33488914
    [No Abstract]   [Full Text] [Related]  

  • 35. Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study.
    Gassner HG; Sherris DA
    Mayo Clin Proc; 2000 Jul; 75(7):701-4. PubMed ID: 10907385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin injection of both sides of the face to treat post-paralytic facial synkinesis.
    Choi KH; Rho SH; Lee JM; Jeon JH; Park SY; Kim J
    J Plast Reconstr Aesthet Surg; 2013 Aug; 66(8):1058-63. PubMed ID: 23683725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multipoint and multilevel injection technique of botulinum toxin A in facial aesthetics.
    Iozzo I; Tengattini V; Antonucci VA
    J Cosmet Dermatol; 2014 Jun; 13(2):135-42. PubMed ID: 24910277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study between intradermal botulinum toxin A and fractional microneedle radiofrequency (FMR) for the treatment of primary axillary hyperhidrosis.
    Rummaneethorn P; Chalermchai T
    Lasers Med Sci; 2020 Jul; 35(5):1179-1184. PubMed ID: 31939036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous vs intramuscular botulinum toxin: split-face randomized study.
    Gordin EA; Luginbuhl AL; Ortlip T; Heffelfinger RN; Krein H
    JAMA Facial Plast Surg; 2014; 16(3):193-8. PubMed ID: 24699554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.